These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway. Marchetti S, Guzzetta G, Flem E, Mirinaviciute G, Scalia Tomba G, Manfredi P. Vaccine; 2018 Feb 14; 36(8):1116-1125. PubMed ID: 29366704 [Abstract] [Full Text] [Related]
8. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. Sullivan NL, Reuter-Monslow MA, Sei J, Durr E, Davis CW, Chang C, McCausland M, Wieland A, Krah D, Rouphael N, Mehta AK, Mulligan MJ, Pulendran B, Ahmed R, Vora KA. J Virol; 2018 Jul 15; 92(14):. PubMed ID: 29743372 [Abstract] [Full Text] [Related]
17. Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence. Harpaz R, van Hoek AJ. J Infect Dis; 2018 Sep 22; 218(suppl_2):S57-S62. PubMed ID: 30247602 [Abstract] [Full Text] [Related]